Target intelligence / Profile preview

Bacterial glycosidase and transporter

Molecular classification
Enzyme (for glycosidases), Transporter (for sugar and glycoside transporters), Families include ABC (ATP-binding cassette), MFS (Major Facilitator Superfamily), PTS (Phosphotransferase system), SusCD (Starch utilization system), Glycosidases are classified in families such as GH (Glycoside Hydrolase) per CAZy database, Other (if referring to multi-component systems in bacteria or composite pathways)
01

Overview

Bacterial glycosidases (glycoside hydrolases) are a large and diverse group of enzymes that catalyze the cleavage of glycosidic bonds in carbohydrates, playing central roles in the degradation of complex glycans, remodeling of bacterial cell walls, and utilization of dietary polysaccharides. They are classified into many families (e.g., GH22, GH24, GH25 for lysozymes; others for metabolic glycosidases) according to the CAZy database based on sequence, fold, and catalytic mechanism. Bacterial glycoside (sugar) transporters are equally diverse, mediating the import of mono-, oligo-, and polysaccharides into bacterial cells for metabolism and growth. Major classes include ATP-binding cassette (ABC) transporters, phosphotransferase systems (PTS), major facilitator superfamily (MFS) transporters, and starch utilization system (SusCD) proteins. Both glycosidases and transporters are cooperative components of bacterial carbohydrate utilization loci (PULs), which allow bacteria to adapt to complex environmental substrates. These protein classes are important in host–microbe interactions, bacterial pathogenesis, and have roles as potential drug targets for modulation of the microbiome or treatment of infectious diseases. Note: For structured database use, refer to individual enzymes (e.g., "N-acetylmuramidase" for lysozyme) or transporters (e.g., "ABC transporter, subfamily X"), rather than broad classes, to achieve precise target identification.

Other names
Bacterial glycoside hydrolaseGlycoside hydrolase (GH)Bacterial sugar transporterOligosaccharide transporterCarbohydrate-active enzyme (CAZyme)Bacterial ABC transporterBacterial MFS transporterBacterial PTS transporter
02

Mechanism of action

Competitive or noncompetitive inhibition of glycosidases (prevents carbohydrate breakdown) Blockage or modulation of transporter activity (impairs nutrient uptake or efflux) Disruption of bacterial metabolism (synergistic with antibiotics or as standalone agents)

03

Biological functions

Carbohydrate catabolismNutrient acquisitionCell wall remodelingMetabolic processing of dietary fibersModulation of host-microbiome interactionGlycan modification
04

Disease associations

Infection (bacterial pathogenesis, virulence)Antibiotic resistance (role of efflux and uptake transporters in resistance)Inflammation (via microbiota/metabolic byproducts)Other (e.g., contribution to gut microbiome health, dysbiosis)
05

Safety considerations

Selective toxicity: Bacterial glycosidases and transporters can resemble those in the host or beneficial symbionts, complicating drug specificityMicrobiome disruption: Targeting broad glycosidase or transporter activity may lead to dysbiosisResistance development: Especially for transporter-targeted drugsAllergic or off-target reactions: Especially for enzyme inhibitors
06

Interacting drugs

Antibiotics targeting cell wall (some bacterial glycosidases are targets for antibiotics, e.g., lysozyme-inhibitors)

3 more in the full profile.

07

Biomarkers

Expression or activity of specific glycosidases in microbiome analyses (e.g., GH family profiling)Presence of specific transporter genes in metagenomic sequencing (e.g., abundance of PTS, ABC transporter loci)Enzymatic activity assays in stool, tissue, or culture samples

Beyond the preview

Go deeper on Bacterial glycosidase and transporter.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial glycosidase and transporter.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call